NASDAQ:NRIX

Nurix Therapeutics Stock Forecast

etoro logo Buy NRIX
*Your capital is at risk
$18.65
+1.10 (+6.27%)
At Close: Jun 22, 2026
AI Analysis AI Analysis of NRIX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add NRIX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

A very strong day for Nurix Therapeutics, Inc. stock price on Monday
(Updated on Jun 22, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 15, 2026 Gain 9.45%

The Nurix Therapeutics, Inc. stock price gained 6.27% on the last trading day (Monday, 22nd Jun 2026), rising from $17.55 to $18.65. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 4.96% from a day low at $17.96 to a day high of $18.85. The price has risen in 7 of the last 10 days and is up by 27.39% over the past 2 weeks. Volume fell on the last day by -2 million shares and in total, 1 million shares were bought and sold for approximately $23.43 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock has broken the wide and weak rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $18.09, a level that may pose a second chance to hit a runner. According to fan-theory $21.32 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

NRIX Signals & Forecast

The Nurix Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $17.34 and $16.57. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, June 05, 2026, and so far it has risen 27.39%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Nurix Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $16.98 and $15.64. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Nurix Therapeutics, Inc. finds support just below today's level at $16.98. If this is broken, then the next support from accumulated volume will be at $15.64 and $15.51.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.89 between high and low, or 4.96%. For the last week, the stock has had daily average volatility of 4.73%.

Our recommended stop-loss: $18.03 (-3.34%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 10 days ago.)

Trading Expectations (NRIX) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Nurix Therapeutics, Inc. to open at $18.49, and during the day (based on 14 day Average True Range), to move between $18.08 and $19.22, which gives a possible trading interval of +/-$1.14 (+/-6.32%) up or down from last closing price. If Nurix Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 6.32% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $16.98, some $1.67 (8.95%) from the current price of $18.65, our system finds the risk reward attractive.

Is Nurix Therapeutics, Inc. stock A Buy?

Nurix Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $18.49 ( 0.88%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

NRIX Performance

Trading levels for NRIX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 19.38 3.90%
R2 19.04 2.07%
R1 18.83 0.95%
Price 18.65
S1 18.15 -2.70%
S2 17.94 -3.82%
S3 17.60 -5.65%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 18.65
S1 16.98 -8.95%
S2 15.64 -16.14%
S3 15.51 -16.84%

FAQ

What is the symbol for Nurix Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Nurix Therapeutics, Inc. is NRIX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Nurix Therapeutics, Inc. Stock?
Nurix Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.

How to buy Nurix Therapeutics, Inc. Stock?
Nurix Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Nurix Therapeutics, Inc. Stock.

What's the current price of Nurix Therapeutics, Inc. Stock?
As of the end of day on the Jun 22, 2026, the price of an Nurix Therapeutics, Inc. (NRIX) share was $18.65.

What is the 52-week high and low for Nurix Therapeutics, Inc. Stock?
The 52-week high for Nurix Therapeutics, Inc. Stock is $22.50 and the 52-week low is $8.20.

What is the market capitalization of Nurix Therapeutics, Inc. Stock?
As of the Jun 22, 2026, the market capitalization of Nurix Therapeutics, Inc. is 1.616B.

When is the next earnings date for Nurix Therapeutics, Inc.?
The upcoming earnings date for Nurix Therapeutics, Inc. is Jul 09, 2026.
Click to get the best stock tips daily for free!
ABOUT NURIX THERAPEUTICS, INC.
Nurix Therapeutics
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malig...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE